Home > News > Company News

MMXXIV API Xi'an

2024-12-19

Nos participatum in CPHI Sinis MMXXIV a October XVI ad XXI, MMXXIV, nostrum umbraculum numerus est w7b56.


Nos occurrit et agere variis API et media negotium cum nostris teloneariorum ad se ferre.


Nostrum comitatu est unus de ducens API developers et artifices in global nationalibus et multinational pharmaceutical industria. Aims to provide quality services, including the development and export of pharmaceutical APIs, FDF preparations, including gemcitabine hydrochloride, celecoxib, bromhexine hydrochloride, elamod, apremilast, tofacitinib citrate, criborole, urapidil hydrochloride, allicin, dexmedetomidine hydrochloride, rocuronium Bromide, Festerenone, risedronate sodium, ensis, difacillin et aliis rudis materiae.

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept